Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).
Saved in:
| Title: | Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). |
|---|---|
| Authors: | Welte, Tobias1 Welte.Tobias@mh-hannover.de, Dellinger, R. Phillip2, Ebelt, Henning3, Ferrer, Miguel4, Opal, Steven M.5, Singer, Mervyn6, Vincent, Jean-Louis7, Werdan, Karl3, Martin-Loeches, Ignacio8,9, Almirall, Jordi10, Artigas, Antonio9, Ignacio Ayestarán, Jose11, Nuding, Sebastian3, Ferrer, Ricard12, Sirgo Rodríguez, Gonzalo13, Shankar-Hari, Manu14, Álvarez-Lerma, Francisco15, Riessen, Reimer16, Sirvent, Josep-Maria17, Kluge, Stefan18 |
| Source: | Intensive Care Medicine. Apr2018, Vol. 44 Issue 4, p438-448. 11p. 1 Diagram, 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03424642 |
|---|---|
| DOI: | 10.1007/s00134-018-5143-7 |
